Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Pharming Q3 EPS $0.01 Down From $0.01 YoY, Sales $66.70M Up From $54.20M YoY

Author: Benzinga Newsdesk | October 26, 2023 01:31am
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.01 per share. This is a 61.54 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $66.70 million in sales this quarter. This is a 23.06 percent increase over sales of $54.20 million the same period last year.

Posted In: PHAR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist